Moore Capital Management »

Bicycle Therapeutics shares owned by Moore Capital Management

Quarter-by-quarter ownership of Bicycle Therapeutics (BCYC) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Bicycle Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicycle Therapeutics held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicycle Therapeutics by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $968k 125k 7.74
2025-06-30 $521k 75k 6.95
2025-03-31 $425k 50k 8.49

More positions owned by Moore Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Meta Platforms Cl A Call Option (META)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Bank of America Corporation (BAC)
Amazon (AMZN)
Freeport-mcmoran CL B Call Option (FCX)
Ally Financial (ALLY)
Aon Shs Cl A (AON)
Spotify Technology S A SHS (SPOT)
Netflix (NFLX)

View all positions for Moore Capital Management

Top funds holding Bicycle Therapeutics

Baker Bros. Advisors
Fcpm Iii Services B.v.
Armistice Capital
Westfield Capital Management Company
Siren
Long Focus Capital Management
Acadian Asset Management
Candriam Luxembourg S.C.A.
Principal Financial Group
Millennium Management
Morgan Stanley
Renaissance Technologies
Silvercrest Asset Management Group
Point72 Asset Management
Leucadia National Corporation

View all funds holding Bicycle Therapeutics